5-phenyl-[1,2,4 ]triazolo[1,5-a]pyridin-2-yl Carboxamides As Jak Inhibitors
A novel compound able to inhibit JAK is disclosed, this compound may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune dis...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
07.01.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A novel compound able to inhibit JAK is disclosed, this compound may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6. |
---|---|
Bibliography: | Application Number: CN201410408911 |